AU2773184A - Spiro(imidazolidine-4,3:-indoline) derivatives - Google Patents

Spiro(imidazolidine-4,3:-indoline) derivatives

Info

Publication number
AU2773184A
AU2773184A AU27731/84A AU2773184A AU2773184A AU 2773184 A AU2773184 A AU 2773184A AU 27731/84 A AU27731/84 A AU 27731/84A AU 2773184 A AU2773184 A AU 2773184A AU 2773184 A AU2773184 A AU 2773184A
Authority
AU
Australia
Prior art keywords
salt
bromo
fluorobenzyl
spiro
indoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27731/84A
Other languages
English (en)
Inventor
David Robert Brittain
Robin Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of AU2773184A publication Critical patent/AU2773184A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU27731/84A 1983-05-05 1984-05-07 Spiro(imidazolidine-4,3:-indoline) derivatives Abandoned AU2773184A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838312379A GB8312379D0 (en) 1983-05-05 1983-05-05 Heterocyclic compounds
GB8312379 1983-05-05

Publications (1)

Publication Number Publication Date
AU2773184A true AU2773184A (en) 1984-11-08

Family

ID=10542245

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27731/84A Abandoned AU2773184A (en) 1983-05-05 1984-05-07 Spiro(imidazolidine-4,3:-indoline) derivatives

Country Status (16)

Country Link
US (1) US4581366A (enExample)
EP (1) EP0125090B1 (enExample)
JP (1) JPS59206384A (enExample)
AU (1) AU2773184A (enExample)
DK (1) DK223484A (enExample)
ES (1) ES8506715A1 (enExample)
FI (1) FI841786L (enExample)
GB (1) GB8312379D0 (enExample)
GR (1) GR73868B (enExample)
HU (1) HU191685B (enExample)
IE (1) IE57356B1 (enExample)
IL (1) IL71735A (enExample)
NO (1) NO841778L (enExample)
NZ (1) NZ208059A (enExample)
PT (1) PT78527B (enExample)
ZA (1) ZA843375B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU566869B2 (en) * 1982-05-11 1987-11-05 Imperial Chemical Industries Plc Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
AU567312B2 (en) * 1982-12-20 1987-11-19 Imperial Chemical Industries Plc 1'-substituted spiro(imidazolidine-4,3'-indoline)-2,2', 5-triones

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616722A (en) * 1995-12-05 1997-04-01 Mcintyre Group, Ltd. Antimicrobial solution of formaldehyde substituted hydantoin and process for preparation
KR101228786B1 (ko) * 2005-08-25 2013-01-31 콜게이트-파아므올리브캄파니 보습 조성물
WO2007091948A2 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490381A (en) * 1979-11-13 1984-12-25 Imperial Chemical Industries Plc 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU566869B2 (en) * 1982-05-11 1987-11-05 Imperial Chemical Industries Plc Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
AU567312B2 (en) * 1982-12-20 1987-11-19 Imperial Chemical Industries Plc 1'-substituted spiro(imidazolidine-4,3'-indoline)-2,2', 5-triones

Also Published As

Publication number Publication date
PT78527B (en) 1986-09-15
FI841786A7 (fi) 1984-11-06
FI841786A0 (fi) 1984-05-04
JPS59206384A (ja) 1984-11-22
GB8312379D0 (en) 1983-06-08
HU191685B (en) 1987-03-30
DK223484D0 (da) 1984-05-04
DK223484A (da) 1984-11-06
NO841778L (no) 1984-11-06
ES532215A0 (es) 1985-08-01
FI841786L (fi) 1984-11-06
IE841112L (en) 1984-11-05
NZ208059A (en) 1987-06-30
EP0125090A2 (en) 1984-11-14
IL71735A (en) 1987-07-31
US4581366A (en) 1986-04-08
PT78527A (en) 1984-06-01
EP0125090A3 (en) 1985-11-27
IE57356B1 (en) 1992-08-12
ZA843375B (en) 1985-01-30
EP0125090B1 (en) 1990-09-12
GR73868B (enExample) 1984-05-08
IL71735A0 (en) 1984-09-30
ES8506715A1 (es) 1985-08-01
HUT34195A (en) 1985-02-28

Similar Documents

Publication Publication Date Title
AU578891B2 (en) Substituted 2-pyridylobenzimidazole derivatives
AU596069B2 (en) Substituted 5-amino-4-hydroxyvaleryl derivatives
AU2290088A (en) Halogen-aniline derivatives
AU2299983A (en) Sulphonamido-benzamide derivatives
AU4442285A (en) Spiro indolino-naphthooxazine
AU2547584A (en) 1- phenyl-2-azole-ethylamino-carbonyl derivatives
AU570667B2 (en) 2-phenyl-3-oxo-3,4-dihydro-benzothiazine(1,4) derivatives
AU588012B2 (en) Cholecalciferol derivatives
AU574785B2 (en) Sulfonylurea derivatives
AU1369983A (en) Imidazo(1,2-alpha) pyridine derivatives
AU7170387A (en) 1,2,4-triazolo-(1,5a) pyrimidine -2- sulfonyl derivatives
AU563950B2 (en) 2,2 -disubstituted-1,3-oxepine derivatives
YU162789A (en) 2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones
AU563849B2 (en) Imidazo(1,5-alpha)pyrimidine derivatives
AU2320284A (en) Pyrrolo-thiazole derivatives
AU2956484A (en) Benzoxadiazol-4-yl-1,4 dibyropyridine derivatives
AU1575383A (en) 1,4-dihyropyridine derivatives
AU7827887A (en) Spiro derivatives
AU3668384A (en) Tetrazole-5-carboxamide derivatives
AU568295B2 (en) 1,2,4-triazol-i-yl-propionitrile derivatives
AU566869B2 (en) Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
AU572645B2 (en) Pyrido-(3,4-b) (1,4)-benzothiazine derivatives
AU546924B2 (en) Indolo(3,2,1-de)(1,5-naphthyridines)
AU2878184A (en) 7-oxo-4-thia-1-azabicyclo(3.2.0.)hept-2-ene derivatives
AU572869B2 (en) 1,6-naphthyridin derivatives